Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trsl.2016.10.003PMID 27815136PMCID PMC5453637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology.

  2016cited by this paper
• Opening CFTR in the Intestine: Flushing on Demand

  2016cited by this paper
• CFTR Activator Increases Intestinal Fluid Secretion and Normalizes Stool Output in a Mouse Model of Constipation

  2016cited by this paper
• Naloxegol for opioid-induced constipation in patients with noncancer pain.

  2014cited by this paper
• Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.

  2013cited by this paper
• A functional CFTR assay using primary cystic fibrosis intestinal organoids

  2013cited by this paper
• Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling.

  2012cited by this paper
• Agents that act luminally to treat diarrhoea and constipation

  2012cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner* ♦

  2012cited by this paper
• Chronic constipation: lessons from animal studies.

  2011cited by this paper
• Epidemiology and burden of chronic constipation.

  2011cited by this paper
• Lubiprostone Reverses the Inhibitory Action of Morphine on Intestinal Secretion in Guinea Pig and Mouse

  2010cited by this paper
• Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.

  2009cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002influential reference
• High-affinity Activators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Conductance Identified by High-throughput Screening*

  2002cited by this paper
• Novel CFTR Chloride Channel Activators Identified by Screening of Combinatorial Libraries Based on Flavone and Benzoquinolizinium Lead Compounds* 210

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001influential reference
• Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice.

  1994cited by this paper
• Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP.

  1980cited by this paper
• Embryogenesis of the enteric ganglia in normal mice and in mice that develop congenital aganglionic megacolon.

  1973cited by this paper
• Effect of cholera enterotoxin on ion transport across isolated ileal mucosa.

  1972cited by this paper

• Synthesis of Aminofuranquinoxalinones from a Two-Step Cascade: Photoinduced TFA-Promoted Coupling of Quinoxalin-2(1H)-ones with 3-Acetamidofuran and Hydrolysis.

  2026cites this paper
• Visible‐Light‐Driven N ‐Alkylation of Quinoxalin‐2(1 H )‐ones With Aryl Diazo Esters

  2026cites this paper
• Sulfur-Promoted Access to 3-Arylquinoxalin-2-ones by Oxidative Coupling of o-Phenylenediamines with Arylacetates.

  2024cites this paper
• Overview of CFTR activators and their recent studies for dry eye disease: a review.

  2023cites this paper
• Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas.

  2023cites this paper
• Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action.

  2023cites this paper
• Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.

  2022cites this paper
• Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis

  2022cites this paper
• Chloride transport modulators as drug candidates.

  2021cites this paper
• SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine

  2021cites this paper
• Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation

  2019cites this paper
• 4,8-Dimethylcoumarin inhibitors of intestinal anion exchanger slc26a3 (down-regulated in adenoma, DRA) for anti-absorptive therapy of constipation.

  2019cites this paper
• STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL.

  2019cites this paper
• SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation.

  2018cites this paper
• High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.

  2017influential citation
• Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.

  2017cites this paper
• Mashiningan Improves Opioid-Induced Constipation in Rats by Activating Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel

  2017cites this paper
• Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents

  2017cites this paper